| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,025 |
3,519 |
$282K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,042 |
1,874 |
$208K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
455 |
435 |
$55K |
| 92587 |
|
658 |
648 |
$36K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,976 |
1,906 |
$33K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
286 |
283 |
$26K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
208 |
204 |
$20K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,448 |
1,389 |
$17K |
| 97802 |
|
683 |
668 |
$13K |
| 90461 |
|
451 |
434 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
249 |
241 |
$10K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$9K |
| 99215 |
Prolong outpt/office vis |
27 |
25 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
39 |
39 |
$5K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
365 |
341 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
149 |
142 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
30 |
29 |
$2K |
| 99177 |
|
444 |
438 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
169 |
160 |
$2K |
| 99188 |
|
90 |
90 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
74 |
37 |
$881.47 |
| 96127 |
|
216 |
164 |
$696.91 |
| 99401 |
|
24 |
20 |
$682.92 |
| 99050 |
|
16 |
15 |
$549.93 |
| 90480 |
|
18 |
18 |
$434.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
27 |
$351.26 |
| 81002 |
|
100 |
97 |
$218.20 |
| 90686 |
|
107 |
107 |
$53.00 |
| 96161 |
|
12 |
12 |
$47.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
29 |
27 |
$1.11 |